Skylight Health Group, Inc. (SLHG) is a healthcare and technology-oriented company, to improve patients’ health. The company provides a range of programs from primary healthcare, sub-specialty, allied healthcare and laboratory testing. The company is also engaged in shifting from a conventional fee-for-service platform to value-based care via apparatus including data analytics and infrastructure.
The price of SLHG stock during the regular trading on January 13, 2022 was $1.04 with a slight gain of 1.27%. At last check in the premarket on January 14, 2022, the stock further significantly surged by 6.26%.
SLHG: Events and Happenings
On November 11, 2021, SLHG reported about launching of already proposed underwritten public offering of its Combined Redeemable Preferred Shares which are entitled to aggregate dividends of 9.25% and are redeemable by the SLHG, at the rate of $25.00 per share. The Company also expected to grant the underwriter a 30-day choice to acquire the Preferred stocks.
On December 15, 2021, SLHG reported about the closure and divestiture of its Relaxed Clarity and Canna Care Documents to the New Frontier Data. On December 07, 2021, SLHG reported about the closure of its underwritten public offering of 275,000 Shares at a public price of $21 per share which generated the gross proceeds of $5,775,000.
On November 29, 2021, SLHG reported that the company’s Executives presented at the Virtual Benchmark Company’s Discovery One on One Video Investor Conference held on December 2, 2021.
SLHG: Key Financials
On November 15, 2021, SLHG reported its financial results for the third quarter ended September 30, 2021. Some of the key updates are as follows
Revenue
Revenue inclined by 269% to $12.2 million during the third quarter 2021 as compared to $3.3 million for the same period of prior year.
Net Loss
Net loss from the operations was $3.9 million for third quarter 2021 as compared to the same period of 2020 when it was $0.2 million.
Conclusion
Although the company’s stock declined 73% from the last six months period primarily due to current pandemic situation which slowed down the economic activities. The current premarket incline is the result of uncertain market environment which helped the stock to gain momentum as predicted by the analysts.
